Evidence map›Paper›PMID 41030061›Full record

ArticleEuropean psychiatry : the journal of the Association of European Psychiatrists2025

Active treatment of affective disturbances may improve functional outcomes in patients in the early state of psychosis: Results of the PRONIA study.

Raimo K R Salokangas, Julian Wenzel, Tiina From, Tuula Ilonen, Reetta-Liina Armio, Heikki Laurikainen, Lauri Tuominen, Maija Walta, Anne Ruef, Carolina Bonivento and 19 more

Abstract readMulticenter Study
In one paragraph

Article in European psychiatry : the journal of the Association of European Psychiatrists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Raimo K R SalokangasDepartment of Psychiatry, https://ror.org/05vghhr25University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0002-8532-1596
Julian WenzelUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany.
Tiina FromDepartment of Psychiatry, https://ror.org/05vghhr25University of Turku, Turku, Finland.ORCID https://orcid.org/0009-0001-9095-0055
Tuula IlonenDepartment of Psychiatry, https://ror.org/05vghhr25University of Turku, Turku, Finland.
Reetta-Liina ArmioDepartment of Psychiatry, https://ror.org/05vghhr25University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0001-7245-3744
Heikki LaurikainenDepartment of Psychiatry, https://ror.org/05vghhr25University of Turku, Turku, Finland.
Lauri TuominenDepartment of Psychiatry, https://ror.org/05vghhr25University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0002-8726-0467
Maija WaltaDepartment of Psychiatry, https://ror.org/05vghhr25University of Turku, Turku, Finland.
Anne RuefDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany.
Carolina BoniventoScientific Institute, IRCCS E. Medea, Pasian di Prato, Udine, Italy.
Dominic DwyerDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany.
Paolo BrambillaDepartment of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Stephen WoodOrygen, The National Centre of Excellence in Youth Mental Health, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-4186-5919
Rachel UpthegroveDepartment of Psychiatry, University of Oxford, Oxford, UK.
Stefan BorgwardtTranslational Psychiatry Unit (TPU), Department of Psychiatry and Psychotherapy, University of Luebeck, Luebeck, Germany.ORCID https://orcid.org/0000-0002-5792-3987
Eva MeisenzahlDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Marlene RosenUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany.
Theresa LichtensteinUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany.
Stephan RuhrmannUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0002-6022-2364
Christos PantelisMelbourne Neuropsychiatry Centre, University of Melbourne & Melbourne Health, Melbourne, Australia.ORCID https://orcid.org/0000-0002-9565-0238
Rebekka LencerTranslational Psychiatry Unit (TPU), Department of Psychiatry and Psychotherapy, University of Luebeck, Luebeck, Germany.ORCID https://orcid.org/0000-0003-4032-7297
Alessandro BertolinoDepartment of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Bari, Italy.
Frauke Schultze-LutterDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.ORCID https://orcid.org/0000-0003-1956-9574
Anita RiecherDepartment of Psychiatry (Psychiatric University Hospital, UPK), University of Basel, Switzerland.ORCID https://orcid.org/0000-0001-6361-8789
Joseph KambeitzUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany.
Lana Kambeitz-IlankovicUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany.
Nikolaos KoutsoulerisDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany.
Jarmo HietalaDepartment of Psychiatry, https://ror.org/05vghhr25University of Turku, Turku, Finland.
PRONIA consortium

Funding

Seventh Framework Programme 602152Turun Yliopistollinen Keskussairaala EVO-Funding
6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe functional outcome of patients with psychotic disturbances is associated with several overlapping premorbid, societal, neuropsychological, and clinical factors. Extracting the factors associated with functional outcomes is important for designing effective mental health interventions.

methodsIn a naturalistic prospective European multicentre study, we analysed the effects of sociodemographic, preadmission, admission, and postadmission precursors on functional outcomes in 296 patients with recent-onset psychosis (ROP) and 262 patients at clinically high risk of psychosis (CHR-P). Functioning was assessed with the Global Assessment of Functioning-symptoms and deficits version-at baseline and at the 9- and 18-month follow-ups.

resultsIn the overall sample, male sex, childhood adversities, poor sociability, scholastic problems, neurocognitive deficits, and greater severity of baseline and follow-up symptoms were associated with poor functional outcomes. In contrast, a favourable work/educational situation and preadmission treatment for nonpsychotic disorders were associated with better functional outcomes. Among ROP patients, neurocognitive deficits and the severity of baseline and follow-up affective and psychotic symptoms were strongly associated with functional outcomes. Among CHR-P patients, premorbid sociability, previous treatment for affective disorders, and follow-up affective symptoms played more significant roles.

conclusionsTo improve functioning in patients in the early stages of psychosis, several factors should be considered, such as sex, childhood adversities, psychosocial development, baseline neurocognitive deficits, work/educational situation, clinical presentations, and follow-up symptoms. Personalized and integrated treatment and rehabilitation measures should be actively continued beyond the first admission period, with a particular focus on addressing both baseline and follow-up affective disturbances.

Indexed as

Mood DisordersOutcome Assessment, Health CarePsychotic DisordersAdolescentAdultEuropeFemaleFollow-Up StudiesHumansMaleProspective StudiesYoung Adultaffective disturbancesfunctional outcomesprospective follow-uppsychosisrisk to psychosis

Identifiers

PMID41030061
PMCPMC12538185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.